For localized information and support, would you like to switch to your country-specific website for {0}?
- Insights
- LabLeaders
- The role of the laboratory in guiding population health management strategies
Key takeaways
- Clinical laboratories are pivotal to population health strategies, providing the data, standards, and guardrails that turn strategy into care at scale
- Gold standards (quality assurance, clinical standardization, automation, and staff support) lift both workflow efficiency and outcomes
- Population health analytics and modern management technology connect lab insights to proactive, equitable care
If population health is the map, the clinical laboratory is the compass. Every day, labs generate high-integrity data that can flag risk earlier, refine clinical pathways, and expose unwarranted variation across care settings. When combined with standardized workflows, intelligent automation, and connected digital tools, that data becomes a force multiplier, freeing scarce staff time, accelerating turnaround, and improving equity in access, testing, and follow-up.1,2
Lab leaders can take several evidence-based actions to strengthen impact: Embed quality and clinical standardization, align staffing to demand, automate safely, and plug lab outputs into population health analytics and management platforms. The aim is simple: Better outcomes for defined populations, delivered efficiently and consistently across the entire healthcare ecosystem.3
The evolving role of clinical laboratories in population health
Clinical laboratories do far more than test and report. They generate longitudinal, high-integrity data that underpins risk stratification, population surveillance, and the evaluation of health interventions. As diagnostics, informatics, and automation advance, laboratories are taking on a co-leadership role in population health initiatives, flagging emerging trends, enabling earlier detection, and informing resource allocation.1,2,4
The COVID-19 pandemic underscored the laboratory’s capacity to scale collection, testing, and reporting at unprecedented speed while upholding rigorous quality standards. Those same capabilities—speed, reliability, and adaptability—are now being applied to proactive models of care well beyond infectious disease.5,6
Understanding population health strategies
Population health strategies aim to improve outcomes for defined groups through data-driven, proactive care models. Unlike public health, which focuses on whole populations, these strategies target specific cohorts—such as patients with the same condition or individuals within the same care network—and align providers, payers, and community partners around shared goals.1,2,7,8
Effective population health solutions often hinge on six moves:7,8
- Define cohorts and stratify risk. Identify specific groups and understand their care patterns.
- Build data foundation. Develop an interoperable, well-governed data foundation and ensure information flows securely across systems.
- Standardize evidence-based pathways with coordinated, team-based workflows that can support consistency in care delivery.
- Close care gaps using proactive outreach and digital or remote care to close gaps; Keep at-risk individuals connected to care.
- Take a holistic approach by integrating social needs and equity into every stage of design; Address nonclinical drivers of health outcomes.
- Measure progress and align incentives with outcomes while tracking a concise set of key performance indicators.
Starting small, with pilot cohorts, enables teams to test, learn, and scale what works through rapid improvement cycles. Laboratories play a pivotal role in this evolution, translating diagnostic data into actionable insights that support population health goals across diverse systems worldwide.
Leveraging data analytics in population health strategies
Population health analytics turn routine lab data into foresight. Using real-world data, statistical and exploratory analysis, and machine learning, labs can:
- Identify rising-risk cohorts and predict demand to inform outreach and staffing: Example: Machine-learning models using routine blood tests can detect early influenza signals. Combined with seasonal trends and lab surveillance, these models forecast 1–2+ week surges, enabling operational planning for staffing and reagent readiness. Health systems and public health agencies routinely publish two-week forecasts, and routine panels can distinguish influenza from respiratory syncytial virus (RSV), supporting model accuracy.9,10
- Detect geographical or demographic disparities in testing and outcomes to guide equity actions: Example: A National Health Service trust in the UK mapped hemoglobin A1c (HbA1c) testing rates and results by postcode and ethnicity. Lower retest rates in two deprived neighborhoods prompted evening diabetes clinics, multilingual SMS reminders, and community phlebotomy pop-ups. Follow-up testing and glycemic control improved measurably over the next quarter.11
- Track adherence to testing pathways, diagnostic stewardship, and care transitions in value-based models: Example: A large health system implemented reflex hepatitis C ribonucleic acid (RNA) testing (automatic RNA on the same sample after a positive antibody result). Completion of confirmatory testing rose markedly, time-to-result decreased, and more patients reached treatment without additional visits — tightening the pathway and reducing loss to follow-up.12
Beyond population-level insights, these analytics optimize bench-level workflow and turnaround times while powering registries, dashboards, and digital quality measures at the system level, closing care gaps and improving outcomes.
Integrating lab insights with population health management software
Population health management technology turns lab outputs into action. Electronic health record (EHR)-integrated tools, care-coordination platforms, and analytics suites can:1,9,13,14
- Aggregate results across sites into cohort dashboards for clinicians and care managers
- Trigger rules-based alerts for abnormal results or missed monitoring intervals
- Surface cost-of-care and quality measures for value-based contracts
- Enable bi-directional data exchange with registries and public health reporting
When configured with shared codes, standardized order sets, and governance protocols, these platforms reduce fragmentation and help teams prioritize the right patients at the right time, improving both lab workflow and care delivery.1,9,13,14
Laboratory gold standards to support population health strategies
Clinical laboratories are integral to the successful implementation, management, and delivery of population health strategies and lab leaders therefore must consider key areas in their operations:
Quality assurance and clinical standardization
Population health demands consistency, and laboratories are central to achieving it. Quality frameworks, such as the National Committee for Quality Assurance (NCQA), allow organizations to measure structure, process, outcomes, and patient experience, helping reduce unwarranted variation and close care gaps.6 Guidance from the World Health Organization (WHO) on laboratory quality management systems emphasizes the importance of accurate, timely, and reliable results for detecting health threats and managing chronic disease at scale. Together, these standards anchor clinical decisions, enable benchmarking across sites, and build trust in cross-system data.6
Optimizing staffing to meet population needs
Workforce pressures can erode throughput, consistency, and the lab’s ability to support population health initiatives. Lab leaders can protect capacity and maintain high-quality services by expanding cross-training, creating clear career pathways, and leveraging digital solutions to automate low-value, manual steps. These actions reduce burnout, improve retention, and sustain service levels during seasonal surges and public health responses.15-17
Standardization and automation in lab operations
Harmonizing instruments, reagents, rules, and workflows across sites cuts error, turnaround time, and cost. Total lab automation, combined with interoperable middleware, streamlines pre-analytical, analytical, and post-analytical steps, enabling reliable results at scale and across networks.17
The future of labs in population health management strategies
Artificial intelligence (AI) and machine learning will deepen the lab’s strategic role: anticipating demand, predicting sepsis or acute deterioration from lab signatures, and personalizing testing intervals for chronic disease.9,10,12
As models ingest multimodal streams (including complete blood count [CBC], chemistry panels, microbiology results, vital signs, prescribing records, and social risk factors), they’ll evolve from generating generic risk flags to producing actionable worklists embedded in the laboratory information system (LIS) and EHR. This supports capacity forecasts, reagent planning, and even predictive maintenance of analyzers.9,12,13
Emerging self-sampling and remote-testing models, paired with robust confirmatory pathways, chain-of-custody controls, and quality oversight, can expand patient access while keeping central labs focused on complex testing and population-level analytics.14
To deliver these innovations safely and equitably, labs will need a durable data platform, standardized terminologies, validated models with drift monitoring, explainable thresholds, and governance frameworks that align incentives with value-based metrics and digital quality measures.9,12-14
Labs at the center of population health transformation
Population health strategies succeed when laboratories set the pace by codifying standards, automating safely, and translating data into action. By leaning into population health analytics and modern management technology, lab leaders can optimize workflow today while shaping proactive, equitable care models for tomorrow.
Now is the time to align quality assurance, clinical standardization, staffing models, and digital population health solutions around a single aim: Delivering better outcomes for defined populations efficiently and consistently at scale.
Why lab standardization matters for population health
Standardized laboratory processes improve quality, consistency, and scalability—enabling better outcomes across populations.
Get our latest insights
Join our community and stay up to date with the latest laboratory innovations and insights.
Contributors
LabLeaders insights
Explore articles from our community
References
- Vesper HW, et al. Am J Clin Nutr. 2016;104:907S–912S. https://doi.org/10.3945/ajcn.115.110387
- Cerezo-Cerezo J, et al. Aten Primaria. 2025;57:103211. https://doi.org/10.1016/j.aprim.2024.103211
- van Ede AFTM, et al. BMC Health Serv Res. 2023;23:910. https://doi.org/10.1186/s12913-023-09915-5
- Sikaris KA. Clin Biochem Rev. 2017;38:107–114. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759162/
- Leber AL, et al. J Clin Microbiol. 2022;60:e00241-22. https://doi.org/10.1128/jcm.00241-22
- World Health Organization. 2020 [Internet; cited 2026 Mar 17]. Available from: https://www.who.int/publications/i/item/9789241548274
- Arkhipova-Jenkins I and Rajupet SR. AJPM Focus. 2023;3:100164. https://doi.org/10.1016/j.focus.2023.100164
- Kindig D and Stoddart G. Am J Public Health. 2003;93:380–383. https://doi.org/10.2105/ajph.93.3.380
- Albrecht S, et al. BMC Med Inform Decis Mak. 2024;24:293. @anihttps://doi.org/10.1186/s12911-024-02702-0
- Hu X, et al. BMC Infect Dis. 2025;25:1088. https://doi.org/10.1186/s12879-025-11502-4
- Pemberton JS, et al. BMJ Open Diabetes Res Care. 2025;13:e004369. https://doi.org/10.1136/bmjdrc-2024-004369
- Castrejón M, et al. Open Forum Infect Dis. 2017;4:ofx109. https://doi.org/10.1093/ofid/ofx109
- Manukyan E, et al. Stud Health Technol Inform. 2023;305:491–494. https://doi.org/10.3233/SHTI230540
- Myers GL. Steroids. 2008;73:1293–1296. https://doi.org/10.1016/j.steroids.2008.06.012
- Yinusa A and Faezipour M. Appl Syst Innov. 2023;6:78. https://doi.org/10.3390/asi6050078
- Mabunda SA, et al. PLOS Glob Public Health. 2025;5:e0004727. https://doi.org/10.1371/journal.pgph.0004727
- Edayan JM, et al. Inform Med Unlocked. 2024;50:101566. https://doi.org/10.1016/j.imu.2024.101566